These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1348787)

  • 1. Short-acting beta-adrenergic blockade and the fetus. A case report.
    Gilson GJ; Knieriem KJ; Smith JF; Izquierdo L; Chatterjee MS; Curet LB
    J Reprod Med; 1992 Mar; 37(3):277-9. PubMed ID: 1348787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal esmolol administration resulting in fetal distress and cesarean section in a term pregnancy.
    Ducey JP; Knape KG
    Anesthesiology; 1992 Oct; 77(4):829-32. PubMed ID: 1358006
    [No Abstract]   [Full Text] [Related]  

  • 3. Esmolol--a short-acting i.v. beta-blocker.
    Med Lett Drugs Ther; 1987 Jun; 29(742):57-8. PubMed ID: 2884558
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
    Gupta A; Naik A; Vora A; Lokhandwala Y
    J Assoc Physicians India; 1999 Oct; 47(10):969-72. PubMed ID: 10778689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esmolol in the treatment of supraventricular tachyarrhythmias.
    Das G; Ferris J
    Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.
    Balser JR; Martinez EA; Winters BD; Perdue PW; Clarke AW; Huang W; Tomaselli GF; Dorman T; Campbell K; Lipsett P; Breslow MJ; Rosenfeld BA
    Anesthesiology; 1998 Nov; 89(5):1052-9. PubMed ID: 9821992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients.
    Ko WJ; Chu SH
    J Am Coll Cardiol; 1994 Feb; 23(2):302-6. PubMed ID: 7905013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esmolol and beta-adrenergic blockade.
    Wolman RL; Fiedler MA
    AANA J; 1991 Dec; 59(6):541-8. PubMed ID: 1686346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esmolol HCl.
    Marden SF; Chulay M
    Crit Care Nurse; 1989; 9(10):12-4. PubMed ID: 2574652
    [No Abstract]   [Full Text] [Related]  

  • 12. Termination of supraventricular tachycardia with intravenous adenosine in a pregnant woman with Wolff-Parkinson-White syndrome.
    Afridi I; Moise KJ; Rokey R
    Obstet Gynecol; 1992 Sep; 80(3 Pt 2):481-3. PubMed ID: 1495713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial.
    Tabbutt S; Nicolson SC; Adamson PC; Zhang X; Hoffman ML; Wells W; Backer CL; McGowan FX; Tweddell JS; Bokesch P; Schreiner M
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):321-8. PubMed ID: 18692637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Esmolol--beta-adrenergic blocking agent with ultrashort action].
    Marenović T; Stojiljković MP; Marković M
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():65-70. PubMed ID: 18193815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.
    Adamson PC; Rhodes LA; Saul JP; Dick M; Epstein MR; Moate P; Boston R; Schreiner MS
    Pediatr Cardiol; 2006; 27(4):420-7. PubMed ID: 16835806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-short-acting beta-adrenergic blockers.
    Frishman WH; Murthy S; Strom JA
    Med Clin North Am; 1988 Mar; 72(2):359-72. PubMed ID: 2894487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden death in a young postoperative patient given esmolol.
    Herschman Z; Dimich I; Singh PP
    Crit Care Med; 1993 Dec; 21(12):1975-6. PubMed ID: 7902808
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity.
    Yamakage M; Iwasaki S; Jeong SW; Satoh J; Namiki A
    Heart Lung; 2009; 38(1):48-55. PubMed ID: 19150530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esmolol, the first ultra-short-acting intravenous beta blocker for use in critically ill patients.
    Blanski L; Lutz J; Laddu A
    Heart Lung; 1988 Jan; 17(1):80-9. PubMed ID: 3276651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
    Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R
    Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.